title: Radionuclide synovectomy - essentials for rheumatologists.
abstract: Radionuclide synovectomy is a minimally invasive method of treating persistent joint inflammation. It involves intra-articular injection of radioactive colloids which induce necrosis and fibrosis of hypertrophic synovial membrane. The most common indication for radiosynovectomy is rheumatoid arthritis, although patients with seronegative spondyloarthropathies, unclassified arthritis, haemophilic arthropathy and other less common arthropathies can also benefit from this method. Radiosynovectomy is safe, well tolerated and efficacious. About 70-80% of patients respond well to the therapy. However, the therapeutic effects are considerably worse in patients with co-existent osteoarthritis and advanced joint degeneration. Despite its advantages, radionuclide synovectomy is not performed as often as it could be, so greater knowledge and understanding of this method are needed. The authors present the most important facts about radiosynovectomy that may help rheumatologists in their daily clinical practice.
authors: Department of Nuclear Medicine, Medical University of Warsaw, Poland.
authors: Marek M
authors: MM
authors: Chojnowski
authors: Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
authors: Anna
authors: A
authors: Felis-Giemza
authors: Department of Nuclear Medicine, Medical University of Warsaw, Poland.
authors: Małgorzata
authors: M
authors: Kobylecka
keywords: hypertrophic-exudative synovitis; radiosynovectomy; rheumatoid arthritis